GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Cognition Inc (NAS:ACOG) » Definitions » Institutional Ownership

ACOG (Alpha Cognition) Institutional Ownership : 37.10% (As of Apr. 12, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Alpha Cognition Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Alpha Cognition's institutional ownership is 37.10%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Alpha Cognition's Insider Ownership is 3.54%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Alpha Cognition's Float Percentage Of Total Shares Outstanding is 0.00%.


Alpha Cognition Institutional Ownership Historical Data

The historical data trend for Alpha Cognition's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Cognition Institutional Ownership Chart

Alpha Cognition Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Institutional Ownership
- - - - -

Alpha Cognition Quarterly Data
Jan20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Institutional Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alpha Cognition Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Alpha Cognition Business Description

Traded in Other Exchanges
N/A
Address
c/o 1200 – 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.